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Debate on hemodynamically significant ductusarteriosus
(hsDA) in premature infants remains unresolved.
The association between patent ductus arteriosus
(PDA) and the most adverse outcomes and comorbid-
ities in preterms (peri-intraventricular haemorrhage,
necrotizing enterocolitis, chronic lung disease, pulmon-
ary haemorrhage and mortality) has led to the integra-
tion of ductal closure into neonatal intensive care.
The recent theory that describes PDA as “an innocent
bystander” is supported by the lack of evidence of signif-
icant benefits on long-term outcomes with therapeutic
interventions. So, the causal relationship between PDA
and comorbidities is questioned. Moreover, PDA can
close spontaneously in a significant proportion of pre-
terms [1].
Both the traditional assumption that all PDA are
pathological and the most recent theory in favor of a
conservative attitudeare oversimplifications [2].
The current management of PDA does not take into
account the wide range of effects attributable to a ductal
shunt. A more logical approach should considerthe duc-
tus as a clinical continuum, from thephysiological PDA
to the pathological hsDA. Placingthe patient in the spec-
trum of “ductal disease” seems to be possible through a
continuous evaluation of the hemodynamic and clinical
consequences of ductal patency [3].
The current definition of an hsDA is almost entirely
based on size [4]. However, the magnitude of transduc-
tal shunt relates not only to the transductal diameter,
but also to the pulmonary and systemic vascular resis-
tance and to the compensatory ability of the immature
myocardium [3].
New echocardiography markers have been evaluated
to estimate the impact of transductal flow on both pul-
monary over circulation (left atrial/aortic ratio, antero-
grade pulmonary artery diastolic flow) and systemic
blood flow (retrograde diastolic flow in descending
aorta, left ventricular output/superior vena cava flow
ratio) [5].
The possibility to evaluate flows in the middle cerebral
artery, renaland superior mesenteric artery with Doppler
ultrasound, allows anearly and plausible detection of
regional hypoperfusion due to the “ductal steal” [3].
Other technologies that enable direct measurement of
tissue oxygenation, such as Near Infrared Spectroscopy
(NIRS), may also be useful to unveil the hemodynamic
effects of PDA [6,7].
We are becoming increasingly aware of the role of
patient’s characteristics (such as genetic profile [8], BNP
levels [9], antioxidant status [10]) in PDA evolution.
According to the current understanding, it seems
appropriate to proposea more tailored approach to the
management of PDA in preterms, based on the integra-
tion between clinical and hemodynamic status.
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